AR002245A1 - Antagonistas del receptor de adhesion, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen y el empleo de los mismos parapreparar medicamentos. - Google Patents
Antagonistas del receptor de adhesion, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen y el empleo de los mismos parapreparar medicamentos.Info
- Publication number
- AR002245A1 AR002245A1 ARP950100091A AR10009195A AR002245A1 AR 002245 A1 AR002245 A1 AR 002245A1 AR P950100091 A ARP950100091 A AR P950100091A AR 10009195 A AR10009195 A AR 10009195A AR 002245 A1 AR002245 A1 AR 002245A1
- Authority
- AR
- Argentina
- Prior art keywords
- prepare
- antagonists
- procedure
- contain
- same
- Prior art date
Links
- 102000019997 adhesion receptor Human genes 0.000 title 1
- 108010013985 adhesion receptor Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000000010 osteolytic effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Abstract
El invento se refiere a los compuestos de fórmula (I), en la que X es O, S, NH, o NA, Y es aziridino, azetidino, pirrolidino, piperidino, hexahidroazepinopiperacino sustituido con R2, R1 es(II)ó(II); R2 es -CrH2r-COOR3; R3 es H,A o Ar;A es alquilo;B es H, A, cicloalquilo de 3 a 7 miembros Ar-CkH2k- o amidino,Ar es fenilo o bencilo sustituido o nó, con A,Cl,Br, I, NO2, CN, OA, OH, NH2, NHA y/o NA2; k es 1, 2, 3 ó 4; m y r son 0, 1, 2, 3, ó 4; y n es 2, 3 ó 4. Loscompuestos del invento inhibenla unión de fibrinógeno a su receptor correspondiente, y pueden ser empleados para el tratamiento de trombosis,osteoporosis, enfermedades tumorales, apoplejías, infarto del miocardio, infecciones, arteriosclerosis y enfermedades osteolíticas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4439846A DE4439846A1 (de) | 1994-11-08 | 1994-11-08 | Adhäsionsrezeptor-Antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002245A1 true AR002245A1 (es) | 1998-03-11 |
Family
ID=6532768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP950100091A AR002245A1 (es) | 1994-11-08 | 1995-11-08 | Antagonistas del receptor de adhesion, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen y el empleo de los mismos parapreparar medicamentos. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5776937A (es) |
| EP (1) | EP0711770A1 (es) |
| JP (1) | JPH08208629A (es) |
| KR (1) | KR100384978B1 (es) |
| CN (1) | CN1069640C (es) |
| AR (1) | AR002245A1 (es) |
| AU (1) | AU704184B2 (es) |
| BR (1) | BR9505109A (es) |
| CA (1) | CA2162223A1 (es) |
| CO (1) | CO4520229A1 (es) |
| CZ (1) | CZ291049B6 (es) |
| DE (1) | DE4439846A1 (es) |
| FI (1) | FI955351A (es) |
| HU (1) | HU217085B (es) |
| NO (1) | NO306113B1 (es) |
| PL (1) | PL183595B1 (es) |
| RU (1) | RU2155762C2 (es) |
| SK (1) | SK281815B6 (es) |
| TR (1) | TR199501389A2 (es) |
| TW (1) | TW316903B (es) |
| UA (1) | UA41928C2 (es) |
| ZA (1) | ZA959434B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2123889T3 (es) * | 1994-11-02 | 1999-01-16 | Merck Patent Gmbh | Antagonistas de receptores de adhesion. |
| US6046331A (en) * | 1998-12-17 | 2000-04-04 | Synaptic Pharmaceutical Corporation | Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
| AU2713600A (en) | 1998-12-23 | 2000-07-31 | G.D. Searle & Co. | Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| JP2002535680A (ja) | 1999-01-27 | 2002-10-22 | ファルマシア・アンド・アップジョン・カンパニー | 延長因子ｐ活性モジュレーターのアッセイ方法 |
| WO2004032856A2 (en) * | 2002-10-07 | 2004-04-22 | Smithkline Beecham Corporation | Compounds |
| CN102796091A (zh) * | 2011-05-24 | 2012-11-28 | 北大方正集团有限公司 | 取代的噁唑烷酮化合物及其制备方法和应用 |
| MA38135B1 (fr) * | 2012-10-29 | 2018-11-30 | Hoffmann La Roche | Dérivés d'oxazolidinone 3,4-disubstituée et leur utilisation comme inhibiteurs des canaux potassiques activés par le calcium |
| CN104230915B (zh) * | 2014-08-29 | 2016-08-17 | 南京大学 | 含噻唑烷二酮的苯基哌嗪衍生物及其制备方法与用途 |
| EP3641769B1 (en) | 2017-06-20 | 2022-06-08 | Imbria Pharmaceuticals, Inc. | 1-[(2,3,4-trimethoxyphenyl)methyl]-piperazine derivative, compositions thereof and methods for increasing efficiency of cardiac metabolism |
| US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
| US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3723797A1 (de) * | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
| US5053393A (en) * | 1988-07-20 | 1991-10-01 | Monsanto Company | Novel platelet-aggregation inhibitor |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| DE4005371A1 (de) * | 1990-02-21 | 1991-08-22 | Merck Patent Gmbh | Oxazolidinone |
| DE4017211A1 (de) * | 1990-05-29 | 1991-12-05 | Merck Patent Gmbh | Oxazolidinone |
| DE4405633A1 (de) * | 1993-05-01 | 1994-11-03 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| DE4332384A1 (de) * | 1993-09-23 | 1995-03-30 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten III |
-
1994
- 1994-11-08 DE DE4439846A patent/DE4439846A1/de not_active Withdrawn
-
1995
- 1995-10-26 EP EP95116889A patent/EP0711770A1/de not_active Withdrawn
- 1995-11-01 UA UA95114761A patent/UA41928C2/uk unknown
- 1995-11-02 AU AU36618/95A patent/AU704184B2/en not_active Ceased
- 1995-11-02 SK SK1368-95A patent/SK281815B6/sk unknown
- 1995-11-06 TW TW084111748A patent/TW316903B/zh active
- 1995-11-06 CA CA002162223A patent/CA2162223A1/en not_active Abandoned
- 1995-11-06 CZ CZ19952888A patent/CZ291049B6/cs not_active IP Right Cessation
- 1995-11-07 NO NO954458A patent/NO306113B1/no not_active IP Right Cessation
- 1995-11-07 FI FI955351A patent/FI955351A/fi not_active IP Right Cessation
- 1995-11-07 ZA ZA959434A patent/ZA959434B/xx unknown
- 1995-11-07 PL PL95311257A patent/PL183595B1/pl not_active IP Right Cessation
- 1995-11-07 KR KR1019950040017A patent/KR100384978B1/ko not_active IP Right Cessation
- 1995-11-07 HU HU9503191A patent/HU217085B/hu not_active IP Right Cessation
- 1995-11-07 BR BR9505109A patent/BR9505109A/pt not_active IP Right Cessation
- 1995-11-07 US US08/551,743 patent/US5776937A/en not_active Expired - Fee Related
- 1995-11-07 CN CN95118753A patent/CN1069640C/zh not_active Expired - Fee Related
- 1995-11-08 RU RU95119427/04A patent/RU2155762C2/ru not_active IP Right Cessation
- 1995-11-08 TR TR95/01389A patent/TR199501389A2/xx unknown
- 1995-11-08 CO CO95052761A patent/CO4520229A1/es unknown
- 1995-11-08 AR ARP950100091A patent/AR002245A1/es unknown
- 1995-11-08 JP JP7313684A patent/JPH08208629A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL311257A1 (en) | 1996-05-13 |
| RU2155762C2 (ru) | 2000-09-10 |
| ZA959434B (en) | 1996-05-15 |
| SK281815B6 (sk) | 2001-08-06 |
| SK136895A3 (en) | 1996-06-05 |
| HUT76052A (en) | 1997-06-30 |
| KR100384978B1 (ko) | 2003-09-02 |
| DE4439846A1 (de) | 1996-05-09 |
| JPH08208629A (ja) | 1996-08-13 |
| UA41928C2 (uk) | 2001-10-15 |
| HU217085B (hu) | 1999-11-29 |
| FI955351A (fi) | 1996-05-09 |
| AU3661895A (en) | 1996-05-23 |
| TW316903B (es) | 1997-10-01 |
| CZ291049B6 (cs) | 2002-12-11 |
| NO954458D0 (no) | 1995-11-07 |
| CZ288895A3 (en) | 1996-06-12 |
| NO306113B1 (no) | 1999-09-20 |
| EP0711770A1 (de) | 1996-05-15 |
| NO954458L (no) | 1996-05-09 |
| CA2162223A1 (en) | 1996-05-09 |
| CO4520229A1 (es) | 1997-10-15 |
| PL183595B1 (pl) | 2002-06-28 |
| HU9503191D0 (en) | 1996-01-29 |
| CN1069640C (zh) | 2001-08-15 |
| CN1132201A (zh) | 1996-10-02 |
| BR9505109A (pt) | 1997-09-09 |
| FI955351A0 (fi) | 1995-11-07 |
| AU704184B2 (en) | 1999-04-15 |
| US5776937A (en) | 1998-07-07 |
| KR960017663A (ko) | 1996-06-17 |
| TR199501389A2 (tr) | 1996-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR007160A1 (es) | Compuestos antagonistas del receptor de adhesion, procedimiento para preparar estos compuestos y preparaciones farmaceuticas que los contienen | |
| ECSP941135A (es) | Antagonistas triciclicos de vasopresina de benzacepina | |
| AR002245A1 (es) | Antagonistas del receptor de adhesion, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen y el empleo de los mismos parapreparar medicamentos. | |
| CL2003002756A1 (es) | Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia. | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| CY1106522T1 (el) | Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο | |
| ES2191048T3 (es) | Derivados de oxazolidinona y compuestos farmaceuticos que los contienen. | |
| ES2053451T3 (es) | Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles. | |
| LV12209A (lv) | Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori | |
| ATE180773T1 (de) | N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren | |
| FI20100200A (fi) | Heteroaryylipiperidiinejä, -pyrrolidiinejä ja -piperatsiineja ja niiden käyttö antipsykoottisina ja analgeettisina aineina | |
| DK51986D0 (da) | Heterocycliske forbindelser, deres fremstilling og anvendelse som insecticide midler | |
| DK1432705T3 (da) | Antibiotika med dobbeltvirkning | |
| MY133897A (en) | N-(4-carb-amimidophenyl) glycineamide derivatives | |
| AR003121A1 (es) | Antagonistas del receptor de adhesión, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y su empleo para preparar medicamentos y combatir enfermedades | |
| FI943728A0 (fi) | Enkefalinaasin ja ACE:n inhibiittoreina käyttökelpoisia uusia aminoasetyylimerkaptojohdannaisia | |
| BR9611400A (pt) | "agentes antimicobiano de benzoxazina". | |
| NO951645L (no) | Syklopeptider | |
| AR019496A1 (es) | Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos | |
| BG99863A (en) | Antagonists of fibrogenous receptor | |
| ES2156255T3 (es) | Procedimiento para preparar antagonistas del receptor de fibrinogeno. | |
| DE69426452D1 (de) | Fibrinogen receptor antagonisten | |
| ATE253359T1 (de) | Antithrombotische mittel | |
| AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. | |
| SE9902387D0 (sv) | New pharmaceutically active compounds |